Characterization of protein therapeutics by mass spectrometry: recent developments and future directions
Authors:
- Guodong ChenGCGuodong Chen
- Bethanne M. WarrackBWBethanne M. Warrack
- Angela K. GoodenoughAGAngela K. Goodenough
- Hui WeiHWHui Wei
- David B. Wang-IversonDWDavid B. Wang-Iverson
- Adrienne A. TymiakATAdrienne A. Tymiak
- 1 January 2011
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 16 (1-2) , 58-64
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Structural Mass Spectrometry in Protein Therapeutics DiscoveryAnalytical Chemistry, 2010
- Hydrogen exchange mass spectrometry: what is it and what can it tell us?Analytical and Bioanalytical Chemistry, 2010
- Application of LC/MS to proteomics studies: current status and future prospectsDrug Discovery Today, 2009
- Mass spectrometry for structural characterization of therapeutic antibodiesMass Spectrometry Reviews, 2008
- LC-MS for protein characterization: current capabilities and future trendsExpert Review of Proteomics, 2008
- Applications of mass spectrometry for the structural characterization of recombinant protein pharmaceuticalsMass Spectrometry Reviews, 2007
- Applications of LC/MS in structure identifications of small molecules and proteins in drug discoveryJournal of Mass Spectrometry, 2007
- Mass Spectrometry and Protein AnalysisScience, 2006
- Recombinant protein therapeutics—success rates, market trends and values to 2010Nature Biotechnology, 2004
- Can the pharmaceutical industry reduce attrition rates?Nature Reviews Drug Discovery, 2004